ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Nexalin Technologies Inc

Nexalin Technologies Inc (NXL)

2.95
0.07
(2.43%)
終了 12月28日 6:00AM
2.92
-0.03
( -1.02% )
プレマーケット: 10:00PM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
2.92
買値
2.89
売値
2.93
出来高
1,585
0.00 日の範囲 0.00
0.2528 52 週間の範囲 4.4899
時価総額
前日終値
2.95
始値
-
時刻
1
@
2.93
最終取引時間
22:00:07
財務取引量
-
VWAP
-
平均取引量 (3 か月)
1,855,014
発行済株式数
12,861,605
配当利回り
-
PER
-8.16
1 株当たり利益 (EPS)
-0.36
歳入
111k
純利益
-4.65M

Nexalin Technologies Inc について

Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic.

セクター
Electromedical Apparatus
業界
Electromedical Apparatus
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Nexalin Technologies Inc is listed in the Electromedical Apparatus sector of the ナスダック市場 with ticker NXL. The last closing price for Nexalin Technologies was US$2.95. Over the last year, Nexalin Technologies shares have traded in a share price range of US$ 0.2528 to US$ 4.4899.

Nexalin Technologies currently has 12,861,605 shares in issue. The market capitalisation of Nexalin Technologies is US$37.94 million. Nexalin Technologies has a price to earnings ratio (PE ratio) of -8.16.

NXL 最新ニュース

Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic

HOUSTON, TX, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS) of the...

New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market

HOUSTON, TX, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) announces that its proprietary Deep Intracranial Frequency Stimulation...

Nexalin Technology CEO Provides Letter to Shareholders

HOUSTON, TX, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today released a letter to shareholders from its CEO Mark White: Dear...

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th

HOUSTON, TX, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on November 5, 2024, at 4:15...

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

HOUSTON, TX, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock Market...

Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease

HOUSTON, TX, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced publication of a landmark study titled, “Altered...

Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA

Gen-3 Halo Headset Designed to Offer Convenient At-Home Treatment Through Virtual Clinic Model Study to Build on Positive Results from Previous Clinical Trial Treating Veterans with Mild Traumatic...

New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients

HOUSTON, TX, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced results from a clinical trial demonstrating improvements...

Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs

HOUSTON, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) announces the appointment of Carolyn Shelton as Senior Vice President of...

Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment

HOUSTON, TX, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) announced its participation in a high-profile Congressional roundtable...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.196.959706959712.732.982.354611462.76785205CS
4-1.27-30.31026252984.194.48992.355133533.58527709CS
122.293365.7097288680.6274.48990.59118550142.61667303CS
261.2675.90361445781.664.48990.5919998722.42680613CS
522.5244638.1193124370.39564.48990.252813417192.02455852CS
1560.228.148148148152.74.48990.25286412911.95620584CS
2600.228.148148148152.74.48990.25286412911.95620584CS

NXL - Frequently Asked Questions (FAQ)

What is the current Nexalin Technologies share price?
The current share price of Nexalin Technologies is US$ 2.92
How many Nexalin Technologies shares are in issue?
Nexalin Technologies has 12,861,605 shares in issue
What is the market cap of Nexalin Technologies?
The market capitalisation of Nexalin Technologies is USD 37.94M
What is the 1 year trading range for Nexalin Technologies share price?
Nexalin Technologies has traded in the range of US$ 0.2528 to US$ 4.4899 during the past year
What is the PE ratio of Nexalin Technologies?
The price to earnings ratio of Nexalin Technologies is -8.16
What is the cash to sales ratio of Nexalin Technologies?
The cash to sales ratio of Nexalin Technologies is 343.02
What is the reporting currency for Nexalin Technologies?
Nexalin Technologies reports financial results in USD
What is the latest annual turnover for Nexalin Technologies?
The latest annual turnover of Nexalin Technologies is USD 111k
What is the latest annual profit for Nexalin Technologies?
The latest annual profit of Nexalin Technologies is USD -4.65M
What is the registered address of Nexalin Technologies?
The registered address for Nexalin Technologies is 1811 SILVERSIDE ROAD, WILMINGTON, DELAWARE, 19810
What is the Nexalin Technologies website address?
The website address for Nexalin Technologies is www.nexalin.com
Which industry sector does Nexalin Technologies operate in?
Nexalin Technologies operates in the ELECTROMEDICAL APPARATUS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
WATTEnergous Corporation
US$ 1.41
(242.90%)
56.28M
NXUNXU Inc
US$ 0.5912
(142.89%)
45.13M
NLSPNLS Pharmaceutics Ltd
US$ 3.82
(109.89%)
10.3M
INTZIntrusion Inc
US$ 4.17
(93.06%)
22.73M
OCTOEightco Holdings Inc
US$ 2.88
(80.00%)
16.77M
LITMSnow Lake Resources Ltd
US$ 0.98
(-38.75%)
9.09M
RPAYRepay Holdings Corporation
US$ 6.01
(-22.35%)
1
LINCLincoln Educational Services Corp
US$ 12.01
(-22.11%)
11
YHGJYunhong CTI Ltd
US$ 0.403
(-20.98%)
1
DALNDallasNews Corporation
US$ 6.01
(-19.33%)
4
WATTEnergous Corporation
US$ 1.41
(242.90%)
56.28M
NXUNXU Inc
US$ 0.5912
(142.89%)
45.13M
SMXSMX Security Matters Public Company
US$ 0.47
(32.92%)
22.87M
INTZIntrusion Inc
US$ 4.17
(93.06%)
22.73M
REKRRekor Systems Inc
US$ 1.87
(43.85%)
20.34M

NXL Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock